Quentin Séry completed his Ph.D. in cancer biology at the University of Nantes in France. He worked on apoptosis and cell signaling pathways involved in the resistance to chemotherapy in Glioblastoma Multiforme. His work was especially focused on EGFR and the Bcl-2 protein family.
Quentin joined Abcam’s Commercial Operations team in 2015 as Scientific Support Specialist.
Get resources and offers direct to your inboxSign up